TRENDING :  Market Movers  |  Top 50   SPY (0.23%)    TSLA (-2.49%)    CANF (1.36%)    BYND (-2.96%)    BTCUSD (%)    ONCS (-3.12%)    AMZN (0.43%)    TVIX (-4.25%)    VXX (-2.07%)    ROKU (6.45%)    ACAD (2.45%)    OIH (-1.43%)    MCHP (-1.44%)    MAXR (-13.79%)    IRBT (0.03%)    IP (-0.24%)    INTC (0.09%)    GDX (0.64%)    FTNT (0.33%)    ECOR (-4.53%)    DNR (3.23%)    DIS (0.05%)    DFRG (2.06%)    CMG (-0.69%)    BIOC (9.74%)

 DPLO - Diplomat Pharmacy

$5.04 [-0.08][-1.37%]

Next Earnings

8/5/2019

AMC

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

3


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $8.00
Low $6.00
Average $7.25
Current $5.04

CompanyAnalyst NamePT ActionActionRatingTargetDate
GuggenheimAnnouncesInitiates Coverage OnHold$6.0004/18/19
Credit SuisseErin WrightLowersMaintainsHold$8.0004/02/19
JP MorganLowersMaintainsHold$7.0003/18/19
Morgan StanleyLowersMaintainsHold$8.0003/18/19
*Last 90 days

OPEN RECOMMENDATIONS

Stocks
Service NameTrader NamePosition TypeTarget %Target PriceTarget Date Issue Date
RenHen InvestmentsRenHen InvestmentsSubscribe326.62 %Subscribe02/25/2002/25/19View


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $DPLO

RECENT SUCCESSFUL RECOMMENDATIONS

No recommendations found.

TRENDING ARTICLES



Waiting on Diplomat Pharmacy to Rebuild

05/13/19
Diplomat Pharmacy NYSE DPLO started off its rebuilding year with mediocre revenue which was to be expected after its specialty pharmacy business ran into stiff competition and the pharmacy benefit manager PBM business lost quite a few clients With most potential clients

New Strong Sell Stocks for May 10th

05/10/19
Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today AMAG Pharmaceuticals Inc AMAG is a developer and manufacturer of therapeutics for maternal and women s health The Zacks Consensus Estimate for its current year earnings has been revised 26 downward over the last 30

Diplomat Pharmacy Inc (DPLO) Q1 2019 Earnings Call Transcript

05/07/19
Image source The Motley Fool Diplomat Pharmacy Inc NYSE DPLO Q1 160 2019 Earnings Call May 7 2019 8 30 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator Hello

Diplomat Pharmaceuticals (DPLO) Reports Q1 Loss, Tops Revenue Estimates

05/07/19
Diplomat Pharmaceuticals DPLO came out with a quarterly loss of 0 19 per share versus the Zacks Consensus Estimate of 0 07 This compares to earnings of 0 20 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise

Diplomat Pharmaceuticals (DPLO) Expected to Beat Earnings Estimates: Should You Buy?

04/30/19
Diplomat Pharmaceuticals DPLO is expected to deliver a year over year decline in earnings on lower revenues when i t report s results for the quarter ended March 2019 This widely known consensus outlook gives a good sense of the company s earnings picture but how the actual results compare